Trials / Completed
CompletedNCT03571841
Sexual Health and Rehabilitation After Ovarian Suppression Treatment
Sexual Health and Rehabilitation After Ovarian Suppression Treatment (SHARE-OS): An Educational Intervention for Young Breast Cancer Survivors
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Dana-Farber Cancer Institute · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
This research study is evaluating an educational intervention for breast cancer survivors who have experienced changes in sexual function after ovarian suppression treatment to reduce the risk of breast cancer recurrence.
Detailed description
The purpose of this research is to study the effectiveness of an educational intervention for breast cancer survivors who have experienced changes in sexual function after ovarian suppression treatment to reduce the risk of cancer recurrence. The aim is to develop an effective intervention to help women manage these changes and restore sexual health and functioning. \- This study consists of attending a group educational session followed by a one-on-one telephone coaching session. * The group educational session will last about 4 hours, and will include information on resources, self-help strategies, and relaxation techniques. * The telephone coaching session will take place four weeks after the group session, and will last about 15 minutes
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Group Session | The 4-hour group session will be structured around three 60-minute modules and creation of a personal action plan |
| BEHAVIORAL | Telephone Booster | One month following the group session, women will receive a telephone booster session (\<15 minutes). This brief telephone check-in is intended to help women review progress with their individualized action-plan, problem-solve around continuing problems, and plan for maintenance moving forward. |
Timeline
- Start date
- 2018-12-01
- Primary completion
- 2019-12-01
- Completion
- 2019-12-01
- First posted
- 2018-06-28
- Last updated
- 2021-11-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03571841. Inclusion in this directory is not an endorsement.